MARKET

LIFE

LIFE

aTyr Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.320
-0.220
-4.85%
Pre Market: 4.300 -0.02 -0.46% 08:00 03/04 EST
OPEN
4.540
PREV CLOSE
4.540
HIGH
4.620
LOW
4.270
VOLUME
488
TURNOVER
--
52 WEEK HIGH
8.33
52 WEEK LOW
2.130
MARKET CAP
43.74M
P/E (TTM)
-1.6296
1D
5D
1M
3M
1Y
5Y
Tissue Culture Market Manufacturers Analysis and Forecast 2020-2027 By Ameco Research
Comserve · 9h ago
Mr. Ron Andrews joins Precipio's Board of Directors
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company's Board of Directors. As the company continues to build its products division around commercializing the technologies it has developed ...
GlobeNewswire · 19h ago
Protein expression market is anticipated to grow at a CAGR of around 10% in terms of revenue during the forecast period 2020 - 2027.
pune, India, Wed, 03 Mar 2021 04:52:55 / Comserve Inc. / -- Protein expression market is anticipated to reach market size of around US$ 5,000 Mn by 2027 and...
Comserve · 1d ago
Love Hemp Group PLC Announces Change of Name
, is pleased to announce that, further to the Company's announcement on 15 February 2021, the change of name from World High Life PLC to Love Hemp Group PLC has become effective.
ACCESSWIRE · 1d ago
Lab-on-a-chip and Microarrays (Biochip) Market Trend Survey 2021 with Top Countries Data Industry Size, Share, Business Growth, Revenue, Trends, Market Demand Penetration and Forecast | With Covid 19 Analysis
Mar 02, 2021 (The Expresswire) -- Global “Lab-on-a-chip and Microarrays (Biochip) Market” Report 2021 contains a comprehensive analysis of the important...
The Express Wire · 1d ago
Bioinformatics Market Demand, Growth, Trend and Business Opportunities with Top Players – Qiagen NV, Agilent Technologies, PerkinElmer and More
Market Insight Reports · 1d ago
Animal Cell Culture Market Report Size 2021 Growth, Share, Product Types and Application, Top Key Players with Sales, Price, Business Overview, SWOT Analysis 2026
The Express Wire · 2d ago
Impact of COVID-19 on Global Heart Valves Market Overview by Size, Share, Qualitative Insights, Recent Acquisitions, Emerging Downstream, Opportunity, and Industry Expansion Strategies 2026
Mar 02, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Heart Valves Market” Research...
The Express Wire · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LIFE. Analyze the recent business situations of aTyr Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LIFE stock price target is 13.33 with a high estimate of 15.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 51
Institutional Holdings: 6.54M
% Owned: 64.55%
Shares Outstanding: 10.12M
TypeInstitutionsShares
Increased
7
236.73K
New
12
171.36K
Decreased
4
279.33K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-3.96%
Pharmaceuticals & Medical Research
-1.89%
Key Executives
Chairman/Independent Director
John Clarke
President/Chief Executive Officer/Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel/Secretary
Nancy Krueger
General Counsel/Secretary
Nancy Denyes
Independent Director
Timothy Coughlin
Independent Director
Jane Gross
Independent Director
Jeffrey Hatfield
Independent Director
Svetlana Lucas
Independent Director
Paul Schimmel
No Data
About LIFE
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The Company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The Company is investigating Resolaris in patients with LGMD2B. The Company is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The Company has not generated any revenues.

Webull offers kinds of aTyr Pharma Inc stock information, including NASDAQ:LIFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LIFE stock methods without spending real money on the virtual paper trading platform.